SCHEMBL18101545

SCHEMBL18101545

Cc1cc2ccc3c(N(c4ccc(F)cc4)c4cccc5c4oc4ccccc45)cc(N(c4ccc(F)cc4)c4cccc5c4oc4ccccc45)c4ccc(c1)c2c34

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
RXFP1 Q9HBX9 2/20 0.33
POLB P06746 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
TNKS O95271 1/20 0.30
PARP1 P09874 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18101518 0.92 MAOB (0.34) MEN1KMT2AMAPTNPSR1POLB
SCHEMBL18101505 0.91 KDM4E (0.33) MEN1KMT2AMAPTPOLBKDM4E
SCHEMBL18798585 0.91 CYP1A2 (0.34) MEN1KMT2AMAPTNPSR1RXFP1
SCHEMBL18101519 0.89 ALOX5 (0.34) KMT2AMAPTPOLBKDM4EALDH1A1
SCHEMBL18101524 0.89 KDM4E (0.35) MEN1KMT2APOLBTDP1KDM4E
SCHEMBL18101610 0.89 MAPT (0.32) MEN1KMT2AMAPTPOLBTDP1
SCHEMBL18101575 0.89 MEN1 (0.32) MEN1KMT2APOLBTDP1
SCHEMBL18101530 0.88 KDM4E (0.32) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL18101529 0.88 KDM4E (0.33) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL18101705 0.88 MEN1 (0.33) MEN1KMT2ATDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3196198-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME Idemitsu Kosan Co., Ltd (JP) 2017-07-26 EP disclosed
US-20160284998-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-09-29 US disclosed
US-20160284998-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160284998-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME EPB41, RPS4X, OR10J3 MEN1 1397/4885KMT2A 2273/4885MAPT 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.